Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DLGAP4 |
| Upstream (Parents) |
|---|
| (<<) DLG3 → DLGAP4 |
| (<<) MSRA → DLGAP4 |
| (<<) DHRS1 → DLGAP4 |
| (<<) TES → DLGAP4 |
| (<<) ALDOA → DLGAP4 |
| Downstream (Children) |
|---|
| DLGAP4 → TH (>>) |
| DLGAP4 → IFIH1 (>>) |
| DLGAP4 → DUSP7 (>>) |
| DLGAP4 → EDA (>>) |
| DLGAP4 → TTC22 (>>) |
| DLGAP4 → SMARCA2 (>>) |
| DLGAP4 → SPP1 (>>) |
| DLGAP4 → EPB41L1 (>>) |
| DLGAP4 → PDGFA (>>) |
| DLGAP4 → MDK (>>) |
| DLGAP4 → CRMP1 (>>) |
| DLGAP4 → DNMT3A (>>) |
| DLGAP4 → SPATA5L1 (>>) |
| DLGAP4 → LIPG (>>) |
| DLGAP4 → SREBF1 (>>) |
